Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
- 1 February 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 343 (8893), 311-322
- https://doi.org/10.1016/s0140-6736(94)91161-4
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)The American Journal of Cardiology, 1993
- Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysisThe American Journal of Cardiology, 1992
- Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarctionThe American Journal of Cardiology, 1991
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM study)The American Journal of Cardiology, 1989
- Patient selection for thrombolytic therapyThe American Journal of Cardiology, 1989
- Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinaseThe American Journal of Cardiology, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Stein's Paradox in StatisticsScientific American, 1977